European approval for new renal denervation system that reduces total ablation time by more than 80 percent

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced the CE Mark approval of its next-generation EnligHTN™ Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension. The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter, reducing total ablation time with the new EnligHTN system by more than 80 percent in comparison to the first generation system, from approximately 24 minutes to four minutes...